Veracyte to Acquire HalioDx, Solidifying Global Leadership in Cancer Diagnostics     Learn More
Veracyte to Acquire HalioDx, Solidifying Global Leadership in Cancer Diagnostics     Learn More
Skip to content
4

SEC Filing Details

Document Details

Form
Filing Date
May 5, 2021
Document Date
May 3, 2021
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Veracyte, Inc.
Issuer
VERACYTE, INC.
Filer
EASTHAM KARIN